Company

Check-Cap is a clinical stage medical diagnostics company leading the development of the first ingestible imaging capsule that utilizes low-dose X-rays for CRC screening. 

The Check-Cap device requires no bowel preparation or invasive procedures, and is designed to detect clinically significant polyps with a high degree of sensitivity. Check-Cap's advanced technology has been proven in animals, and is designed to offer several advantages compared to current screening procedures.

Founded in early 2005, Check-Cap recruited a team of world-class experts in physics, software engineering, electronics, mechanics and physiology, who have been developing a multi-disciplinary imaging solution for imaging and screening of the colon. The system includes a capsule, a receiver, proprietary imaging software and an associated database for web based access and analysis.

Check-Cap's advanced technology has been proven in animals and promises to offer several significant advantages compared to other colonic screening procedures.

Colorectal cancer is the Western world's second largest cancer killer, despite being largely preventable and/or treatable with early screening. Check-Cap's technology is designed to be the first to offer CRC screening through a structural exam without the pain, discomfort and embarrassment experienced during currently available screening methods, and thus is uniquely positioned to increase screening compliance without compromising accuracy. We intend to develop our technology into the next breakthrough, gold standard in colon cancer screening to address the need of an estimated 35 million patients annually in a fast-growing $25B market.

for more information about the market opportunity and clinical need